Results 51 to 60 of about 581 (153)
Obstructive sleep apnea (OSA) is characterized by recurrent upper‐airway collapse, which generates key nocturnal stressors including intermittent hypoxia, sleep fragmentation, intrathoracic pressure stress, and sympathetic activation. These physiological disturbances converge on shared biological mechanisms, including oxidative stress, inflammation ...
Nhi Ho Thi Thuy +8 more
wiley +1 more source
SOLRIAMFETOL TITRATION AND ADMINISTRATION: DOSING AND TITRATION STRATEGIES IN PATIENTS WITH OSA STARTING SOLRIAMFETOL [PDF]
HARAMANDEEP SINGH +6 more
openaire +1 more source
Towards Mechanism‐Informed Treatments for Mental Health
Neuropsychiatric disorders impose a major global health burden, and current treatments, which historically mostly targeted dopamine and serotonin dysfunctions, often provide only partial, symptomatic relief. This review highlights emerging evidence that additional neuromodulator systems, including acetylcholine, norepinephrine, and endocannabinoids ...
Iker Bengoetxea de Tena +27 more
wiley +1 more source
Narcolepsy: Pathophysiology, Diagnosis, Management, and Future Directions, a Narrative Review
This visual summary outlines the pathophysiology of narcolepsy, driven by hypocretin loss, and details its clinical diagnosis, current management strategies, and the shift toward future disease‐modifying therapies like orexin agonists and immunomodulation.
Natasha Elaine Hastings +12 more
wiley +1 more source
Solriamfetol for attention deficit hyperactivity disorder [PDF]
Ahmed, Naguy +3 more
openaire +2 more sources
Solriamfetol, a dopamine and norepinephrine reuptake inhibitor (DNRI) indicated for the treatment of excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, was subjected to comprehensive forced degradation studies in ...
Venkateswara Rao Bhoomi +6 more
doaj +1 more source
A scoping review of clinical approach and personalized management of obstructive sleep apnea
Obstructive sleep apnea (OSA) is common yet frequently underdiagnosed. It not only impairs the sleep quality but also associated with multiple comorbidities. This review article aims at providing an update on the diagnosis and management of OSA through a
Nileena Namboodiripad Kakkattu Mana +4 more
doaj +1 more source
Narcolepsy 2025 (with an Australasian perspective)
Abstract Narcolepsy is a disorder of central hypersomnolence, which, while uncommon, can carry profound implications for affected individuals. Despite this, it remains under‐recognised within the medical community and presents frequent diagnostic and treatment challenges in the Australasian setting.
Amelia Lin +3 more
wiley +1 more source
Orexin deficiency drives narcolepsy Type 1, leading to excessive daytime sleepiness, cataplexy, and REM intrusions. This review highlights recent advances (2023–2025) in molecular mechanisms, diagnostics, and emerging orexin‐targeted therapies with the potential for disease modification.
Rameesha Rauf +9 more
wiley +1 more source
Treatment of narcolepsy and pregnancy: a review
This is a chapter review of pregnancy state in patients with narcolepsy which aims to provide a review of literature regarding pregnancy in patients with narcolepsy, physiology of hormonal change during pregnancy on sleep, pharmacologic and non ...
Kullatham Kongpakpaisarn, Christine Won
doaj +1 more source

